SEI Investments
DNLI icon

SEI Investments’s Denali Therapeutics DNLI Stock Holding History

SEI Investments’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.52M Buy
58,989
+6,754
+13% +$139K ﹤0.01% 2096
2026
Q1 		$1M Buy
+52,235
New +$1.04M ﹤0.01% 2349
2025
Q2 		– Sell
-17,276
Closed -$235K – 2817
2025
Q1 		$235K Sell
17,276
-6,771
-28% -$130K ﹤0.01% 2428
2024
Q4 		$490K Sell
24,047
-2,229
-8% -$57.1K ﹤0.01% 2196
2024
Q3 		$765K Buy
26,276
+3,606
+16% +$89.4K ﹤0.01% 2038
2024
Q2 		$526K Buy
22,670
+10,598
+88% +$203K ﹤0.01% 2139
2024
Q1 		$248K Buy
12,072
+211
+2% +$3.96K ﹤0.01% 2373
2023
Q4 		$255K Sell
11,861
-399
-3% -$7.9K ﹤0.01% 2372
2023
Q3 		$253K Sell
12,260
-4,261
-26% -$108K ﹤0.01% 2362
2023
Q2 		$488K Buy
16,521
+153
+0.9% +$4.3K ﹤0.01% 2137
2023
Q1 		$377K Buy
16,368
+3,667
+29% +$101K ﹤0.01% 2246
2022
Q4 		$353K Sell
12,701
-3,317
-21% -$98.7K ﹤0.01% 2147
2022
Q3 		$492K Buy
16,018
+5,660
+55% +$184K ﹤0.01% 2093
2022
Q2 		$305K Sell
10,358
-160
-2% -$4.19K ﹤0.01% 2315
2022
Q1 		$328K Sell
10,518
-834
-7% -$28.7K ﹤0.01% 2270
2021
Q4 		$498K Sell
11,352
-433
-4% -$20.5K ﹤0.01% 2103
2021
Q3 		$588K Buy
11,785
+3,174
+37% +$179K ﹤0.01% 2003
2021
Q2 		$675K Sell
8,611
-11,119
-56% -$688K ﹤0.01% 1953
2021
Q1 		$1.43M Buy
19,730
+1,864
+10% +$125K ﹤0.01% 1607
2020
Q4 		$1.5M Sell
17,866
-490
-3% -$29.6K ﹤0.01% 1519
2020
Q3 		$658K Buy
+18,356
New +$553K ﹤0.01% 1790

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SEI Investments's DNLI Position: Q2 2026 in Review

SEI Investments increased its Denali Therapeutics (DNLI) stake by 13% in Q2 2026, buying an estimated $139K and bringing the position to 58,989 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #2096.

SEI Investments first reported a position in DNLI in Q3 2020 and has held it in 21 quarters since. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • SEI Investments held 58,989 shares of Denali Therapeutics worth $1.52M as of Q2 2026.
  • SEI Investments bought 6,754 Denali Therapeutics shares in Q2 2026, an estimated $139K.
  • Denali Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2096 holding.
  • SEI Investments first reported a position in Denali Therapeutics in Q3 2020 and has held it in 21 quarters since.
  • 292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.